Antibody Persistence and Safety through 6 Months after Heterologous Orally Aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously

Lairun Jin, Rong Tang, Shipo Wu, Xiling Guo, Lihua Hou, Xiaoqin Chen, Tao Zhu, Jinbo Gou, Haitao Huang, Jin Zhong, Hongxing Pan, Lunbiao Cui, Yin chen, Xin Xia, Jialu Feng, Xue Wang, Qi Zhao, XiaoYu Xu, Zhuopei Li, Xiaoyin Zhang, Jingxin Li, Wei Chen, Fengcai Zhu
doi: https://doi.org/10.1101/2022.07.26.22278072

Article Information

doi 
https://doi.org/10.1101/2022.07.26.22278072
History 
  • July 28, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Lairun Jin1,a,
  2. Rong Tang2,a,
  3. Shipo Wu3,a,
  4. Xiling Guo2,a,
  5. Lihua Hou3,
  6. Xiaoqin Chen4,
  7. Tao Zhu5,
  8. Jinbo Gou5,
  9. Haitao Huang5,
  10. Jin Zhong4,
  11. Hongxing Pan2,
  12. Lunbiao Cui2,
  13. Yin chen2,
  14. Xin Xia6,
  15. Jialu Feng6,
  16. Xue Wang5,
  17. Qi Zhao5,
  18. XiaoYu Xu7,
  19. Zhuopei Li6,
  20. Xiaoyin Zhang1,
  21. Jingxin Li2,6,8,b,*,
  22. Wei Chen3,b,* and
  23. Fengcai Zhu1,2,6,8,b,*
  1. 1School of Public Health, Southeast University, Nanjing, Jiangsu Province, P.R China
  2. 2National Health Commission (NHC) Key laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Jiangsu Province, P.R China
  3. 3Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, P.R China
  4. 4Donghai County Center for Disease Control and Prevention, Donghai, Jiangsu Province, P.R China
  5. 5Cansino Biologics Inc., Tianjin, P.R China
  6. 6School of Public Health, Nanjing Medical University, Nanjing, Jiangsu Province, P.R China
  7. 7Vazyme Biotech Co., Ltd, Nanjing, Jiangsu Province, P.R China
  8. 8Institute of Global Public Health and Emergency Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu Province, P.R China
  1. ↵*Correspondence: Fengcai Zhu, School of Public Health, Southeast University, No.87 Dingjiaqiao, Hunan Road, Gulou district, Nanjing 210009, Jiangsu Province, P.R China; National Health Commission (NHC) Key laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), No.172 Jiangsu Road, Nanjing 210009, Jiangsu Province, P.R China (jszfc{at}vip.sina.com). or Jingxin Li, National Health Commission (NHC) Key laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), No.172 Jiangsu Road, Nanjing 210009, Jiangsu Province, P.R China (jingxin42102209{at}126.com). or Wei Chen, Beijing Institute of Biotechnology, Academy of Military Medical Sciences, No. 20 East Street, Fengtai District, Beijing 100039, P.R China (cw0226{at}foxmail.com).

  1. ↵a L.J., R.T., S.W. and X.G. contributed equally to this work.

  2. ↵b J.L., W.C. and F.Z. contributed equally to this work.

Back to top
Posted July 28, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Antibody Persistence and Safety through 6 Months after Heterologous Orally Aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously
Lairun Jin, Rong Tang, Shipo Wu, Xiling Guo, Lihua Hou, Xiaoqin Chen, Tao Zhu, Jinbo Gou, Haitao Huang, Jin Zhong, Hongxing Pan, Lunbiao Cui, Yin chen, Xin Xia, Jialu Feng, Xue Wang, Qi Zhao, XiaoYu Xu, Zhuopei Li, Xiaoyin Zhang, Jingxin Li, Wei Chen, Fengcai Zhu
medRxiv 2022.07.26.22278072; doi: https://doi.org/10.1101/2022.07.26.22278072
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area